BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29664054)

  • 1. Limited Role of Promoter Methylation of
    Sun LL; Liu Y; Sun X; Pan L; Wu D; Wang YD
    Chin Med J (Engl); 2018 Apr; 131(8):939-944. PubMed ID: 29664054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Promoter methylation of DAPK1, RAR-β and MGMT in exfoliated cervical cytology and its clinical application].
    Zhong ZJ; Yang JX; Cao DY; Sun Y; Sun LL; Cheng XM; Chen J; Lang JH; Shen K
    Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):196-200. PubMed ID: 22781071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DAPK1, MGMT and RARB promoter methylation as biomarkers for high-grade cervical lesions.
    Sun Y; Li S; Shen K; Ye S; Cao D; Yang J
    Int J Clin Exp Pathol; 2015; 8(11):14939-45. PubMed ID: 26823825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting cervical intraepithelial neoplasia recurrence in HIV-infected and -noninfected women by detecting aberrant promoter methylation in the CDH1, TIMP3, and MGMT genes.
    Teixeira da Costa Lodi C; Michelin MA; Miranda Lima MI; Murta EFC; Braga LDC; Montes L; Melo VH
    Arch Gynecol Obstet; 2018 Nov; 298(5):971-979. PubMed ID: 30218185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.
    Shen-Gunther J; Wang CM; Poage GM; Lin CL; Perez L; Banks NA; Huang TH
    Clin Epigenetics; 2016; 8(1):96. PubMed ID: 27651839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of MGMT promoter hypermethylation with squamous intraepithelial lesion and cervical carcinoma: A meta-analysis.
    Huang J; Luo JY; Tan HZ
    PLoS One; 2019; 14(10):e0222772. PubMed ID: 31574102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based case-control study on DAPK1, RAR-β2 and MGMT methylation in liquid-based cytology.
    Sun LL; Cao DY; Yang JX; Li H; Zhou XR; Song ZQ; Cheng XM; Chen J; Shen K
    Arch Gynecol Obstet; 2012 May; 285(5):1433-9. PubMed ID: 22116316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III.
    Terra AP; Murta EF; Maluf PJ; Caballero OL; Brait M; Adad SJ
    Tumori; 2007; 93(6):572-9. PubMed ID: 18338492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma.
    Banzai C; Nishino K; Quan J; Yoshihara K; Sekine M; Yahata T; Tanaka K;
    Int J Clin Oncol; 2014 Feb; 19(1):127-32. PubMed ID: 23494221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between human papillomavirus and Epstein - Barr virus DNA and gene promoter methylation of RB1 and CDH1 in the cervical lesions: a transversal study.
    McCormick TM; Canedo NH; Furtado YL; Silveira FA; de Lima RJ; Rosman AD; Almeida Filho GL; Carvalho Mda G
    Diagn Pathol; 2015 Jun; 10():59. PubMed ID: 26032781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter methylation of p16(INK4A), hMLH1, and MGMT in liquid-based cervical cytology samples compared with clinicopathological findings and HPV presence.
    Spathis A; Aga E; Alepaki M; Chranioti A; Meristoudis C; Panayiotides I; Kassanos D; Karakitsos P
    Infect Dis Obstet Gynecol; 2011; 2011():927861. PubMed ID: 21747645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.
    Boers A; Wang R; van Leeuwen RW; Klip HG; de Bock GH; Hollema H; van Criekinge W; de Meyer T; Denil S; van der Zee AGJ; Schuuring E; Wisman GBA
    Clin Epigenetics; 2016; 8():29. PubMed ID: 26962367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression.
    Iliopoulos D; Oikonomou P; Messinis I; Tsezou A
    Oncol Rep; 2009 Jul; 22(1):199-204. PubMed ID: 19513524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate status and aberrant DNA methylation are associated with HPV infection and cervical pathogenesis.
    Flatley JE; McNeir K; Balasubramani L; Tidy J; Stuart EL; Young TA; Powers HJ
    Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2782-9. PubMed ID: 19755648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High risk HPV testing in the triage of repeat ASC-US and LSIL.
    Veijalainen O; Tuomisaari S; Luukkaala T; Mäenpää J
    Acta Obstet Gynecol Scand; 2015 Sep; 94(9):931-6. PubMed ID: 26053676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility study.
    Salta S; Maia-Moço L; Estevão-Pereira H; Sequeira JP; Vieira R; Bartosch C; Petronilho S; Monteiro P; Sousa A; Baldaque I; Rodrigues J; Sousa H; Tavares F; Henrique R; Jerónimo C
    Int J Cancer; 2021 Dec; 149(11):1916-1925. PubMed ID: 34460099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings.
    Yang N; Eijsink JJ; Lendvai A; Volders HH; Klip H; Buikema HJ; van Hemel BM; Schuuring E; van der Zee AG; Wisman GB
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3000-7. PubMed ID: 19843677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of P16 expression in the triage of liquid-based cervical cytology with atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions.
    Ma YY; Cheng XD; Zhou CY; Qiu LQ; Chen XD; Lü WG; Xie X
    Chin Med J (Engl); 2011 Aug; 124(16):2443-7. PubMed ID: 21933584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort.
    van Leeuwen RW; Oštrbenk A; Poljak M; van der Zee AGJ; Schuuring E; Wisman GBA
    Int J Cancer; 2019 Feb; 144(4):746-754. PubMed ID: 30259973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
    Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.